SCHEMBL9610495

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL9610494	0.88	SMN1; SMN2 (0.36)	ALDH1A1KDM4EMAPTMAPK1PTPN1
	SCHEMBL9610530	0.83	CDC25B (0.33)	ALDH1A1TAS1R3TAS1R1MAPTPTPN1
	SCHEMBL9610500	0.83	TAS1R3 (0.42)	ALDH1A1TAS1R3TAS1R1KDM4EMAPT
	SCHEMBL9610490	0.77	KIF11 (0.34)	KDM4E
	SCHEMBL9610507	0.76	RARA (0.36)	TAS1R3TAS1R1RARARARBRARG
	SCHEMBL9610493	0.74	CAPN1 (0.30)	—
	SCHEMBL9610492	0.74	POLB (0.31)	—
	SCHEMBL24985292	0.73	LMNA (0.41)	ALDH1A1TAS1R3TAS1R1
	SCHEMBL14665535	0.72	TAS1R3 (0.39)	ALDH1A1TAS1R3TAS1R1MAPTMAPK1
	SCHEMBL9610529	0.72	MAPT (0.35)	ALDH1A1KDM4EMAPTMAPK1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.